
Sign up to save your podcasts
Or
A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.
4.8
2626 ratings
A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.
135 Listeners
111 Listeners
26,356 Listeners
27 Listeners
182 Listeners
2 Listeners
348 Listeners
56 Listeners
366 Listeners
136 Listeners
8 Listeners
29 Listeners
181 Listeners
48 Listeners
40 Listeners